Basic Information
Biotech Startup VoluMetrix is Committed to Developing Breakthrough Monitoring Technologies to Enhance People's Well-being. Currently, the company’s product, NIVAHF, has received Breakthrough Device Designation from the U.S. FDA. NIVAHF is an investigational medical device designed to monitor venous waveforms (a novel physiological signal) in heart failure patients.
VoluMetrix, LLC
Nashville,Tennessee,United States of America
15~50 people
January 01, 2015
--

